World Cancer Metabolism Summit 2/1-2/2012
 

http://cancer-metabolism-summit.com/



World Cancer Metabolism Summit Translating the Revival of Warburg into Commercial Drug Development 1 - 2 February 2012
Washington, D.C.

About

With millions of dollars of investment from pharmaceutical giants, this meeting focuses on the exciting research field that everyone is watching: cancer metabolism.

Given the pharmaceutical industry’s heavy investment into the research of cancer metabolism, now is the perfect time to come together to cash in on the benefits of cancer starving drugs. Seize your chance to take part in the fast growing community which is translating the Warburg phenomenon into a new generation of cancer therapies.
Sharing strategies and approaches to drug discovery will play a vital step in your company’s progression of metabolic targeting cancer drugs. With large pharma and leading biotechs now ready to reveal those techniques there has never been a meeting so focused on pushing metabolic targeting drugs into the clinic and through to the market.
With the agenda designed by cutting edge research with experts at GSK, AstraZeneca, Genentech, Myrexis, Cornerstone and Warburg Glycomed, the World Cancer Metabolism summit is unchallenged in its industry relevance. It is designed to be specific and relevant to cancer metabolism and will deliver solutions to current issues faced by drug developers.